Mohamed SN - Search Results

1

Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis.

Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S, Davis PJ. Bergh JJ, et al. Among authors: mohamed sn. Endocrinology. 2005 Jul;146(7):2864-71. doi: 10.1210/en.2005-0102. Epub 2005 Mar 31. Endocrinology. 2005. PMID: 15802494

2

Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface.

Davis FB, Mousa SA, O'Connor L, Mohamed S, Lin HY, Cao HJ, Davis PJ. Davis FB, et al. Circ Res. 2004 Jun 11;94(11):1500-6. doi: 10.1161/01.RES.0000130784.90237.4a. Epub 2004 Apr 29. Circ Res. 2004. PMID: 15117822

3

Anti-angiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anti-cancer efficacy.

Mousa SA, Mohamed S. Mousa SA, et al. Oncol Rep. 2004 Oct;12(4):683-8. Oncol Rep. 2004. PMID: 15375485

4

Human alphavbeta3 integrin potency and specificity of TA138 and its DOTA conjugated form (89)Y-TA138.

Mousa SA, Mohamed S. Mousa SA, et al. J Cardiovasc Pharmacol. 2005 Feb;45(2):109-13. doi: 10.1097/01.fjc.0000151927.89154.9a. J Cardiovasc Pharmacol. 2005. PMID: 15654258

5

Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor.

Mousa SA, Mohamed S. Mousa SA, et al. Thromb Haemost. 2004 Sep;92(3):627-33. doi: 10.1160/TH04-02-0069. Thromb Haemost. 2004. PMID: 15351861

6

Pro-angiogenesis action of thyroid hormone and analogs in a three-dimensional in vitro microvascular endothelial sprouting model.

Mousa SA, Davis FB, Mohamed S, Davis PJ, Feng X. Mousa SA, et al. Int Angiol. 2006 Dec;25(4):407-13. Int Angiol. 2006. PMID: 17164749

7

Antiangiogenesis and anticancer efficacy of TA138, a novel alphavbeta3 antagonist.

Mousa SA, Mohamed S, Wexler EJ, Kerr JS. Mousa SA, et al. Anticancer Res. 2005 Jan-Feb;25(1A):197-206. Anticancer Res. 2005. PMID: 15816539 Free article.

8

Stable over-expression of estrogen receptor-alpha in ECV304 cells inhibits proliferation and levels of secreted endothelin-1 and vascular endothelial growth factor.

Ali SH, O'Donnell AL, Mohamed S, Mousa S, Dandona P. Ali SH, et al. Mol Cell Endocrinol. 1999 Jun 25;152(1-2):1-9. doi: 10.1016/s0303-7207(99)00065-9. Mol Cell Endocrinol. 1999. PMID: 10432218

9

Overexpression of estrogen receptor-alpha in the endometrial carcinoma cell line Ishikawa: inhibition of growth and angiogenic factors.

Ali SH, O'Donnell AL, Mohamed S, Mousa S, Dandona P. Ali SH, et al. Gynecol Oncol. 2004 Dec;95(3):637-45. doi: 10.1016/j.ygyno.2004.08.034. Gynecol Oncol. 2004. PMID: 15581976

10

Estrogen receptor-alpha in the inhibition of cancer growth and angiogenesis.

Ali SH, O'Donnell AL, Balu D, Pohl MB, Seyler MJ, Mohamed S, Mousa S, Dandona P. Ali SH, et al. Cancer Res. 2000 Dec 15;60(24):7094-8. Cancer Res. 2000. PMID: 11156416

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters